ArticleAntimicrobial agents and chemotherapy2017
Concentration and Variety of Carbapenemase Producers in Recreational Coastal Waters Showing Distinct Levels of Pollution.
Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Silent Waterborne Carriers of Carbapenem-Resistant Gram-Negative Bacilli and Antimicrobial Resistance Genes in Rio de Janeiro's Aquatic Ecosystems.Antibiotics (Basel, Switzerland) · 2026Article
- Silent Threat Evolution: Critically Important Carbapenem and Colistin Resistance Genes in the Natural Aquatic Environment.Antibiotics (Basel, Switzerland) · 2026Review
- Importance of wastewater-based and environmental surveillance for monitoring resistance to next-generation antibiotics.Future microbiology · 2025Article
- Massive culture-based approach for the screening of AmpC, ESBL, and carbapenemase producers from rectal swabs.Microbiology spectrum · 2025Article
- Carbapenem-resistant bacteria in the environment.Arhiv za higijenu rada i toksikologiju · 2025Review
- Genomic insights into the evolution, pathogenicity, and extensively drug-resistance of emerging pathogensFrontiers in cellular and infection microbiology · 2024Article
- Expansion of healthcare-associated hypervirulent KPC-2-producingOne health (Amsterdam, Netherlands) · 2023Article
- Review of Antimicrobial Resistance in Wastewater in Japan: Current Challenges and Future Perspectives.Antibiotics (Basel, Switzerland) · 2022Review
- Complete Genome Sequence ofMicrobiology resource announcements · 2022Article
- Convergence of virulence and resistance in international clones of WHO critical priority enterobacterales isolated from Marine Bivalves.Scientific reports · 2022Article
- Inter-species geographic signatures for tracing horizontal gene transfer and long-term persistence of carbapenem resistance.Genome medicine · 2022Article
- Identification, Characterization, and Virulence Gene Expression of Marine Enterobacteria in the Upper Gulf of Thailand.Microorganisms · 2022Article
- Environmental spreading of clinically relevant carbapenem-resistant gram-negative bacilli: the occurrence of blaBMC microbiology · 2022Article
- Genomic Analysis of a Highly Virulent NDM-1-ProducingFrontiers in microbiology · 2022Article
- Molluscs-A ticking microbial bomb.Frontiers in microbiology · 2022Review
- Colistin-resistant Enterobacter kobei carrying mcr-9.1 and blaTransboundary and emerging diseases · 2021Article
- Carbapenem Resistance among Marine Bacteria-An Emerging Threat to the Global Health Sector.Microorganisms · 2021Review
- A Novel Multidrug Resistant, Non-TnFrontiers in microbiology · 2021Article
- Multidrug-resistant enterobacteriaceae in coastal water: an emerging threat.Antimicrobial resistance and infection control · 2020Article
- The Hydric Environment: A Hub for Clinically Relevant Carbapenemase Encoding Genes.Antibiotics (Basel, Switzerland) · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbapenemase-producing bacteria cause difficult-to-treat infections related to increased mortality in health care settings. Their occurrence has been reported in raw sewage, sewage-impacted rivers, and polluted coastal waters, which may indicate their spread to the community. We assessed the variety and concentration of carbapenemase producers in coastal waters with distinct pollution levels for 1 year. We describe various bacterial species producing distinct carbapenemases not only in unsuitable waters but also in waters considered suitable for primary contact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.